[Coxib instead of NSAID plus gastric acid inhibitor. Protection for the small intestine].
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D007783:Lactones / Q000009:adverse effects* / Q000627:therapeutic use; D009288:Naproxen / Q000009:adverse effects* / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000139:chemically induced* / Q000517:prevention & control; D010438:Peptic Ulcer Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D054328:Proton Pump Inhibitors; D012306:Risk; D013450:Sulfones
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D007783:Lactones; D054328:Proton Pump Inhibitors; D013450:Sulfones; C116926:rofecoxib; D009288:Naproxen